Alveus, Lilly, Viking and Amgen are testing maintenance strategies as durability becomes a bigger focus in obesity R&D.

The pharma and biotech industries are constantly in flux. Every year, pharma professionals converge on a number of large ...

Dr. John Tsai grabbed the reins of global R&D this year with a clear mandate: extend Daiichi’s oncology momentum beyond its ...

The error points to a big question for pharma as AI gains autonomy and high-profile failures sharpen safety concerns: What ...

Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory diseases.

Roche announced it's building autonomous AI-powered labs; how a clinical hold on an epilepsy trial could impact Biohaven ...

Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...